Biotechnology Stocks
| # | Letzte 7 Tage | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 3674 |  KRRO Korro Bio, Inc. - Common Stock | 10.58 USD | +0.86% | +6.87% | -17.34% | -72.80% | 155.80 M USD | ||
| 3676 |  MOLN Molecular Partners AG - American Depositary Shares | 3.81 USD | +0.79% | -2.81% | -8.85% | +3.53% | 153.83 M USD | ||
| 3677 |  NERV Minerva Neurosciences, Inc - Common Stock | 3.22 USD | -1.53% | -2.13% | -21.46% | +33.06% | 153.75 M USD | ||
| 3682 |  ABOS Acumen Pharmaceuticals, Inc. - Common Stock | 2.10 USD | 0.00% | 0.00% | -24.73% | -8.30% | 151.87 M USD | ||
| 3695 |  CDXS Codexis, Inc. - Common Stock | 1.36 USD | -3.55% | -2.16% | -4.23% | -51.43% | 148.93 M USD | ||
| 3700 |  VYGR Voyager Therapeutics, Inc. - Common Stock | 2.37 USD | -4.05% | -12.87% | -25.94% | -49.03% | 146.03 M USD | ||
| 3706 |  ARMP Armata Pharmaceuticals, Inc. Common Stock | 3.85 USD | 0.00% | +11.92% | -30.51% | -52.88% | 143.15 M USD | ||
| 3708 |  AVXL Anavex Life Sciences Corp. - Common Stock | 1.54 USD | +0.65% | -18.09% | -43.17% | -83.70% | 142.75 M USD | ||
| 3713 |  RNA Atrium Therapeutics, Inc. - Common Stock | 8.26 USD | +4.16% | +0.49% | -20.88% | -88.26% | 141.29 M USD | ||
| 3724 |  OTLK Outlook Therapeutics, Inc. - Common Stock | 0.56 USD | -5.08% | -5.08% | -11.11% | +36.59% | 136.33 M USD | ||
| 3725 |  IPHA Innate Pharma S.A. - American Depositary Shares | 1.48 USD | -2.63% | -5.13% | -22.51% | -25.25% | 138.70 M USD | ||
| 3737 |  TLSA Tiziana Life Sciences Ltd - Common Shares | 1.13 USD | +2.73% | 0.00% | +17.71% | -47.69% | 136.17 M USD | ||
| 3750 |  ADAG Adagene Inc - ADS, each representing 1.25 | 2.78 USD | -1.07% | -6.08% | -21.25% | +40.40% | 131.73 M USD | ||
| 3754 |  SPRB Spruce Biosciences, Inc. - Common Stock | 45.54 USD | +2.57% | +3.20% | -18.11% | -74.38% | 130.88 M USD | ||
| 3762 |  NRXP NRX Pharmaceuticals, Inc. - Common Stock | 2.89 USD | -0.34% | -0.34% | -13.73% | +62.36% | 125.12 M USD | ||
| 3763 |  HUMA Humacyte, Inc. - Common Stock | 0.45 USD | -4.26% | -11.76% | -22.41% | -72.39% | 125.01 M USD | ||
| 3765 |  TNXP Tonix Pharmaceuticals Holding Corp. - Common Stock | 7.28 USD | -3.58% | -21.72% | -41.85% | -51.50% | 124.86 M USD | ||
| 3771 |  HURA TuHURA Biosciences, Inc. - Common Stock | 1.93 USD | -2.53% | -3.02% | -3.98% | -24.90% | 122.99 M USD | ||
| 3775 |  CBUS Cibus, Inc. - Class A Common Stock | 1.59 USD | -1.85% | -2.45% | +1.92% | +5.30% | 121.52 M USD | ||
| 3776 |  TNYA Tenaya Therapeutics, Inc. - Common Stock | 0.54 USD | +1.89% | -5.26% | -18.18% | -75.68% | 121.08 M USD |
Nachrichten Biotechnology Stocks
Pharvaris: HAE-Medikament zeigt in Lancet-Studie schnellere Symptomlinderung
Kymera Therapeutics: Raymond James startet Coverage mit „Outperform“-Rating
Raymond James startet Coverage für Nektar-Aktie mit "Market Perform"
Raymond James nimmt Coverage für Palisade Bio mit "Outperform" auf
Raymond James bestätigt Liquidia-Rating trotz rechtlicher Unsicherheiten
Ginkgo Bioworks gewährt NSF X-Labs Zugang zu autonomem Labor
AbCellera präsentiert Phase-1/2-Daten zu Medikamentenkandidaten gegen Menopause-Beschwerden
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
 CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |